Navigation Links
Single Embryo IVF Increase Chances of Having Child Sans Risky Multiple Births

According to a new research that studied hazardous multiple births, women undergoing IVF (In vitro fertilization) could be treated with single embryo without reducing their chances of having a child.

The researchers found that that moving one embryo at a time to the womb can marginally raise success rates.

The study, led by Yacoub Khalaf, of Guys Hospital, London, may increase pressure on fertility clinics to adopt similar methods to reduce multiple births.

The programme at Guys, has shown that one embryo can be transferred successfully in women under 35 who generate at least four good-quality embryos.

In the study, that analysed patients under 35: the procedure raised chances from 35 per cent to 41 per cent.

Multiple pregnancy rates decreased by almost half the percentage, from 37 to 19 per cent.

The high success rate with single embryos was made possible by keeping embryos in culture for five days, rather than the practised three days, before its transfer to the womb.

The extra time makes the embryos to become blastocysts, which are more possible to be implanted. The balls of 100 cells also make it easier for embryologists to assess for quality.

Since not every embryo will develop into a blastocyst, it is not appropriate for every woman to have a blastocyst transfer.

It is advisable only for those who generate plenty of embryos.

According to Mr Khalaf, multiple birth problem can be countered without hampering the chances of the patient to start a family.

It is a myth that single embryo transfer has to lower the success rate, he said. If you select the right patients, and use blastocyst transfer, it can be just as good. We believe firmly that a twin pregnancy is not an ideal outcome. People think it is two for the price of one, but the risks are real and we see heartache time after time. I would encourage eve
'"/>




Page: 1 2

Related medicine news :

1. Single gene analysis for diagnosis of a range of blood disorders
2. Single drug for bipolar disorder
3. Treating Testicular Cancer With A Single Dose Of Chemotherapy
4. Decreasing Multiple Births By Single Embryo Transfers
5. Single gene skin cancer cause
6. Drug Firms To Produce Single Pill AIDS Treatment
7. Malaria May Gain Resistance To Single Drug Prescriptions
8. Single Women with Baby Cravings Can Actually Cradle their Own, Courtesy NHS
9. Thai Doctors Removed 421 Kidney Stones From A Single Person
10. Single Dose Of Azithromycin Could Cure Trichiasis
11. Effects Of Certain Food Related To Single Pain Receptors
Post Your Comments:
(Date:9/5/2008)...odels are enhanced by taking into account risk fac... according to research teams led by epidemiologist... Center in two complementary papers appearing in t.... , In the first study to focus on African-Ameri...creased exposure to certain risks. Based upon thes...
(Date:9/4/2008)...e Medicare Advantage (MA) plans will be paid an av...red to what the same enrollee would have cost in t...ccording to a new report from The Commonwealth Fun...dated by the Medicare Improvements for Patients an... effect beginning in 2010 had been fully in place...
(Date:9/4/2008)...pancreatic tumors , , THURSDAY, Sept. 4 ...coveries involving genetic mutations of two deadly...reatic cancer -- may lead to new treatments and ev...present the most complete genetic analysis to date...map of these deadly cancers," Kenneth Kinzler, a p...
(Date:9/4/2008)...RNewswire/ -- Martin Schiff, M.D.,is an illustriou...weight,control and weight loss. His career is deta...he West," "Who,s Who in America," "Who,s Who in,th...and other honor rolls., Dr. Schiff recently retir...ate, misleading theories and notions concerning we...
Breaking Medicine News(10 mins):Health News:Creating lung cancer risk models for specific populations refines prediction 2Health News:Creating lung cancer risk models for specific populations refines prediction 3Health News:Extra payments to Medicare Advantage plans to total $8.5 billion in 2008 2Health News:Genetic Mutations Linked to Deadly Cancers 2Health News:Genetic Mutations Linked to Deadly Cancers 3Health News:Genetic Mutations Linked to Deadly Cancers 4Health News:Phone World-famed Martin Schiff, M.D., at 310-454-6172 for Free Weight Loss 'No Diet, No Stuff' Method. Hates Diets, Loves to Have People Help Themselves 2
...alyzing the neuronal receptor activity in the post...ia, researchers at the University of Pennsylvania ...ists at the City University of New York, have foun...h level of erbB4 receptor activity and reduced NMD...
...a of subjecting drug addicts to shock therapy as a... debates and controversies. Now, the Scottish Exec...rapy //. Shock therapy technically labeled as Neu...with the use of self-adhesive electrodes inserted ...
...bane childcare center, a tuberculosis case alerts ...diagnosed in a childcare worker, who works at the ...Mount Ommaney in west Brisbane. Dr Michael Whitby... Medical Association (AMA) said that children’s (m...
...ast Victoria Sale Hospital's two pediatricians, Jo...ions with three months notice with three months no...xpected for at least six months. This has led to .... Sale obstetrician Dr Refaat Guirguis has said th...
Other Medicine News:Health News:Schizophrenia Complicates With Altered Receptor Activity 2Health News:Schizophrenia Complicates With Altered Receptor Activity 3
(Date:9/5/2008)... SOUTH SAN FRANCISCO, Calif., Sept. 5 /PRNewswir...pany focused on small molecule LFA-1 inhibitors,to...uticals, Inc. (Nasdaq:,SNSS) today announced SARco...mall molecule LFA-1 product candidate for T-cell m...ntered into a license agreement providing,SARcode ...
(Date:9/4/2008)... MELBOURNE, Australia, Sept. 4 /- C...is commencing enrolment for its Phase Ib/II,study ... anticancer agent,in patients with an aggressive ...rme (GBM)., The GBM clinical trial is the first P...umor indications for the company and the second in...
(Date:9/4/2008)...Another Roche first in TaqMan(R) real-time PCR tes... lab, PLEASANTON, Calif., Sept. 4 /PRNewswi...as approved the Roche COBAS(R) TaqMan(R) HBV Test,...s DNA approved in the U.S.,The test uses Roche,s r...Hepatitis B virus DNA in a patient,s blood. Doctor...
(Date:9/4/2008)... BIRMINGHAM, Ala., Sept. 4 /- South...tional Institutes of Health (NIH) has selected,the...olecular Libraries,Probe Production Center Network...twork -- is part of the Molecular Libraries Progra...en scientific knowledge of the human,genome and va...
Breaking Medicine Technology:SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 2SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 3Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Kaiser Permanente CEO Receives Diversity Leadership Award 5201 1Kaiser Permanente CEO Receives Diversity Leadership Award 5201 2United Therapeutics Reports Third Quarter 2007 Financial Results 1642 1United Therapeutics Reports Third Quarter 2007 Financial Results 1642 2United Therapeutics Reports Third Quarter 2007 Financial Results 1642 3United Therapeutics Reports Third Quarter 2007 Financial Results 1642 4United Therapeutics Reports Third Quarter 2007 Financial Results 1642 5United Therapeutics Reports Third Quarter 2007 Financial Results 1642 6United Therapeutics Reports Third Quarter 2007 Financial Results 1642 7United Therapeutics Reports Third Quarter 2007 Financial Results 1642 8United Therapeutics Reports Third Quarter 2007 Financial Results 1642 9Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes 1637 1Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes 1637 2Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes 1637 3Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes 1637 4Triumph 1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint 5194 1Triumph 1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint 5194 2Triumph 1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint 5194 3Triumph 1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint 5194 4Triumph 1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint 5194 5Triumph 1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint 5194 6
...WIRE) -- June 14,2007 -- Targeted Genetics Corpor...the dose escalation arm of the ongoing Phase,I/II ...atory,arthritis. Philip J. Mease, M.D., clinical p... Medicine, chief of rheumatology,clinical research...an with Seattle Rheumatology Associates and the le...
...- Prolexys,Pharmaceuticals and announced today a p...ive small molecule anti-tumor agent,erastin. Prol...eomics technology to understand the mechanism of a...the June 14, 2007 issue,of the journal Nature reve...pendent anion channels (VDACs) -- a novel target f...
Other Medicine Technology:Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 2Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 3Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 4Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 5Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 6Prolexys Pharmaceuticals and Columbia University Researchers,Publish Study on Anti-Tumor Properties of a Selective Small,Molecule Anti-Tumor Agent With Novel Mechanism of Action 2Prolexys Pharmaceuticals and Columbia University Researchers,Publish Study on Anti-Tumor Properties of a Selective Small,Molecule Anti-Tumor Agent With Novel Mechanism of Action 3
Delicate side cutting wire cutter with carbide inserts.
Curved osteotome for bone removing.
...t. It is created using the Panoramic200 and is use...ye and non-eye diseases and disorders. It is avail... non-reimbursable. The optomap provides the practi...tients retina which is viewed on-screen by the pra...
...amera is a state-of-the-art, office-based nuclear ...riendly gantry, and provides full sized fields of ...linic you need a flexible system that can work aro... Pulse reduces the costs of adding a gamma camera ...
Medicine Products: